Citreum, UAB - financials and debts

Company age: 34 y. 11 mo.

Update

Citreum - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 588,281 556,128 525,619 824,030 1,230,745 1,207,078 451,407 456,010
Profit before tax 30,706 8,046 35,064 194,986 489,477 251,096 -25,203 -50,737
Net profit 26,026 6,675 29,733 165,687 416,053 213,346 -25,203 -50,737
Equity 395,367 402,042 420,010 585,697 942,926 1,073,919 931,070 880,333
Liabilities 37,648 59,765 37,981 93,272 88,740 18,871 23,283 28,140
Non-current assets 16,408 29,635 31,069 25,341 17,687 5,533 33,157 35,627
Current assets 415,560 430,548 425,863 652,889 1,013,648 1,086,357 920,263 871,846
Total assets 431,968 460,183 456,932 678,230 1,031,335 1,091,890 953,420 907,473
Taxes paid
STI taxes - - - - - 341,184 123,407 15,264
Social insurance contributions - - - - - 24,429 22,416 21,907
Financial indicators
Revenue change y/y +4.1% -5.5% -5.5% +56.8% +49.4% -1.9% -62.6% +1.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 6.0% 1.5% 6.5% 24.4% 40.3% 19.5% -2.6% -5.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 6.6% 1.7% 7.1% 28.3% 44.1% 19.9% -2.7% -5.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 4.4% 1.2% 5.7% 20.1% 33.8% 17.7% -5.6% -11.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 5.2% 1.4% 6.7% 23.7% 39.8% 20.8% -5.6% -11.1%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 76,732 79,447 75,088 119,136 175,821 172,440 74,204 76,002

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Citreum - Social security debts

The company had no debts to Sodra

Citreum - VMI tax arrears

From To Overdue, €
2025-07-03 2025-07-20 35.42
2025-04-18 2025-04-18 4.04
2025-02-20 2025-02-20 0.04
2025-01-30 2025-02-03 0.04
2024-12-30 2025-01-15 0.04
2024-12-19 2024-12-20 0.04
2024-12-01 2024-12-10 0.04
2024-11-28 2024-11-30 0.11
2024-10-28 2024-11-23 0.11
2024-09-29 2024-10-13 0.11

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Citreum, UAB, a Private Limited Liability Company (code 133076330), operates in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €456.0K, slightly above 2024 revenue of €451.4K, but far below the €1.21M reported in 2023. Net profit remained negative at €50.7K in 2025, compared with a €25.2K loss in 2024 and a €213.3K profit in 2023, showing a clear deterioration in profitability over the two-year period. The 2025 profit margin was -11.1%. Balance sheet indicators remained stable and conservative: total assets stood at €907.5K, equity at €880.3K, and liabilities at €28.1K. The equity ratio was 97.0% and debt-to-equity 0.03, indicating very limited leverage. Asset turnover was 0.50x, while ROE and ROA were -5.8% and -5.6%, respectively. Revenue per employee was €76.0K, and profit per employee was -€8.5K.